# Uviquity

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/uviquity

- Industry: Semiconductors
- Headquarters: Raleigh, US
- Website: uviquity.com
- Total disclosed funding: $6.7M
- Latest round: Seed (Aug 22, 2024)
- Investors on record: 3

## About

Uviquity, Inc. is a technology company specializing in semiconductor chip development for generating pathogen-eliminating far-UVC light, focusing on effective disinfection solutions across industries. Founded in 2022, Uviquity, Inc. is dedicated to developing innovative disinfection technology. The company is based in North Carolina, US and has completed one notable deal. In August 2024, Uviquity, Inc. raised USD 6.6 million in seed funding led by Emerald Development Managers, with participation from AgFunder and MANN+HUMMEL. Uviquity's core offering is its proprietary semiconductor chip designed to generate human-safe, pathogen-eliminating far-UVC light. This innovative technology focuses on providing effective disinfection solutions for various applications, including air, food, and water purification. By harnessing the power of far-UVC light, Uviquity aims to address significant public health challenges associated with pathogens in these essential resources. The end users of this technology encompass a wide range of industries, including healthcare facilities, food processing plants, and municipal water systems, all seeking to enhance safety and minimize microbial contamination. Uviquity's products are marketed primarily in North America and Europe, catering to a growing demand for advanced disinfection technologies in these regions. Uviquity generates revenue through a direct-to-consumer model as well as business-to-business partnerships. The company engages with various clients, including healthcare providers, food manufacturers, and municipal entities, to offer its disinfection solutions. Transactions typically occur through sales contracts that stipulate the installation and maintenance of their far-UVC light systems, tailored to the specific needs of each client. Uviquity's pricing may vary based on the scope and scale of the implementation, reflecting the complexity of the environments being disinfected. The flagship products are positioned to provide significant value to organizations looking to enhance hygiene and safety protocols, which is crucial in today’s health-conscious market landscape. Uviquity, Inc. plans to utilize the USD 6.675 million raised in Seed funding to further its research and development efforts. The company aims to design and launch new products in the disinfection technology sector, although specific release dates have not been disclosed. Additionally, Uviquity is targeting expansion into new geographic markets, specifically focusing on enhancing its presence in North America and Europe by the end of 2025.

## Funding rounds

- Seed, Aug 22, 2024, $6.7M — MANN+HUMMEL, Emerald Development Managers, AgFunder

## Investors

- MANN+HUMMEL — Seed
- Emerald Development Managers (https://capitalatlas.ai/funds/emerald-development-managers) — Seed
- AgFunder (https://capitalatlas.ai/funds/agfunder) — Seed